Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Matinas Biopharma Hl (MTNB)

1.05   0.148 (16.46%) 11-29 21:44
Open: 0.95 Pre. Close: 0.9016
High: 1.07 Low: 0.93
Volume: 6,400,864 Market Cap: 209M
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company is headquartered in Bedminster, New Jersey and currently employs 15 full-time employees. The firm focuses on identifying and developing novel pharmaceutical products. The firm's technology utilizes lipid-crystal nano-particle cochleates to nano-encapsulate existing drugs, which is designed to make safer, more tolerable, less toxic and orally bioavailable. The firm's technology combines the use of lipids as active pharmaceutical ingredients (APIs) and the use of lipids in cochleate-shaped lipid-crystal nano-particle drug delivery vehicles. The Company’s product candidates include, MAT2203 and MAT2501.The Company's anti-infective product candidate, MAT 2203, is an application of its cochleate delivery technology to a spectrum anti-fungal drug called amphotericin B. The firm's MAT2501 is an orally administered, encochleated formulation of the spectrum IV-only aminoglycoside antibiotic agent amikacin, utilizes the Company's lipid-crystal, nanoparticle delivery technology.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.071 - 1.075 1.075 - 1.078
Low: 0.92 - 0.925 0.925 - 0.928
Close: 1.043 - 1.05 1.05 - 1.056

Technical analysis

as of: 2020-11-29 9:25:07 AM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 1.25     One year: 1.46
Support: Support1: 0.86    Support2: 0.73
Resistance: Resistance1: 1.07    Resistance2: 1.25
Pivot: 0.83
Moving Average: MA(5): 0.89     MA(20): 0.83
MA(100): 0.82     MA(250): 0.98
MACD: MACD(12,26): 0.02     Signal(9):
Stochastic oscillator: %K(14,3): 84.32     %D(3): 77.78
RSI: RSI(14): 74.09
52-week: High: 2.49  Low: 0.49  Change(%): -18.0
Average Vol(K): 3-Month: 163483  10-Days: 260370

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
MTNB has closed above the upper band by 30.6%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 75.4% wider than normal. The large width of the bands suggest high volatility as compared to MTNB's normal range. The bands have been in this wide range for 0 bars. This is a sign that the current trend might continue.

Headline News

Fri, 23 Oct 2020
Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2020 Financial and Operational Results on November 6, 2020 - GlobeNewswire

Mon, 19 Oct 2020
Matinas BioPharma Announces Unanimous DSMB Approval to Progress into Second Cohort of Patients in the EnACT Study of MAT2203 (Oral Amphotericin B) for the Treatment of Cryptococcal Meningitis - GlobeNewswire

Tue, 15 Sep 2020
Matinas BioPharma Announces Positive End of Phase 2 Meeting with the FDA for MAT9001 in Severe Hypertriglyceridemia (SHTG) - GlobeNewswire

Thu, 10 Sep 2020
Matinas BioPharma to Participate on Anti-Fungal CEO Panel During the M-VEST Virtual Conference Series Sponsored by Maxim Group - GlobeNewswire

Thu, 27 Aug 2020
Matinas BioPharma Completes Enrollment of ENHANCE-IT Study of MAT9001 Against Vascepa® - GlobeNewswire

Mon, 10 Aug 2020
Matinas BioPharma Reports Second Quarter 2020 Financial Results and Operational Highlights - GlobeNewswire

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 199
Shares Float (M) 162
% Held by Insiders 8.55
% Held by Institutions 20.78
Shares Short (K) 16,300
Shares Short P. Month (K) 16,490

Stock Financials

EPS -0.121
EPS Est This Year -0.290
EPS Est Next Year -0.240
Book Value (p.s.) 0.350
Profit Margin
Operating Margin
Return on Assets (ttm) -22.0
Return on Equity (ttm) -36.4
Qtrly Rev. Growth
Gross Profit (p.s.) -0.056
Sales Per Share
EBITDA (p.s.) -0.111
Qtrly Earnings Growth
Operating Cash Flow (M) -17
Levered Free Cash Flow (M) -11

Stock Valuations

PE Ratio -8.68
PEG Ratio
Price to Book value 3.00
Price to Sales
Price to Cash Flow -12.43

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.